Lineage Cell Therapeutics Inc LCTX Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
AMEX
Lineage Cell Therapeutics Inc (LCTX)
Lineage Cell Therapeutics Inc (LCTX) Financials

Lineage Cell Therapeutics Inc (LCTX)

0.558

0.056

(11.16%)

Closed 21 December 8:00AM

Delayed by 15 minutes

0.5822

0.0242

( 4.34% )

Pre Market: 8:36PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	28.303	-12.651	-33.459	-10.31	-17.692	-30.457	-17.621	-19.126
Return on Equity (%)	32.444	-13.554	-35.858	-11.508	-20.011	-46.251	-32.27	-32.078
Return on Invested Capital (%)	-47.906	-232.573	-298.085	-27.259	-24.583	-53.021	-28.294	-37.037
Operating Margin (%)	332.061	-649.306	-941.079	-547.198	-1200.657	-996.775	-175.556	-260.279
Net Profit Margin (%)	566.807	-577.675	-922.013	-333.115	-1130.832	-990.993	-178.691	-240.201
Book Value Per Share	1.17	1.24	0.701	0.349	0.244	0.197	0.086	0.027
Earnings Per Share	0.326	-0.157	-0.362	-0.078	-0.135	-0.254	-0.154	-0.123
Cash Per Share	0.215	0.29	0.186	0.063	0.213	0.329	0.067	0.203
Working Capital Per Share	0.163	0.282	0.232	0.341	0.237	0.38	0.241	0.117
Operating Profit Per Share	0.054	0.026	0.037	0.021	0.009	0.022	0.086	0.051
EBIT Per Share	0.181	-0.184	-0.371	-0.128	-0.143	-0.255	-0.152	-0.133
EBITDA Per Share	0.181	-0.184	-0.371	-0.128	-0.143	-0.255	-0.152	-0.133
Free Cash Flow Per Share	0.305	-0.173	-0.362	-0.095	-0.148	-0.257	-0.156	-0.123

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	102.78M	126.87M	127.14M	149.8M	153.1M	169.48M	170.09M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	170.09M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-260.142	N/A	N/A	N/A	-454.155	N/A	N/A
Net Profit Margin (%)	N/A	-183.236	N/A	N/A	N/A	-453.047	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	105.37M
Price to Earnings Ratio	-4.92
Price to Sales Ratio	11.81
Price to Cash Ratio	2.98
Price to Book Ratio	1.7
Dividend Yield	-

Share Statistics

Shares Outstanding	188.84M
Average Volume (1 week)	1.97M
Average Volume (1 Month)	3.2M
52 Week Change	-46.09%
52 Week High	1.61
52 Week Low	0.481

More Ratios Coming Soon!

Lineage Cell Therapeutics

Norfolk Southern

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions